Dr. Tuyen Bujnicki

1995 - 2001 Study of Biotechnology at the Technische Universität Berlin, Germany

2002 - 2005 Ph.D. in Biochemistry at Forschungszentrum Jülich and the Heinrich-Heine-University-Düsseldorf, Germany

2005 - 2006 Postdoctoral Fellow at the Institute of Biological Information Processing, Forschungszentrum Jülich

2006 - 2009 Postdoctoral Fellow at the Institute of Biochemistry, University Münster, Germany

2009 - 2014 Parental leave

2014 - 2019 Postdoctoral Fellow in the group “diagnostic” at the Institute of Complex Systems, Structural Biochemistry, Forschungszentrum Jülich

Since October 2019 Project manager of SuFIDA Innovation lab at Forschungszentrum Jülich

Since February 2020 Quality manager for the institute

1. Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, Pils M, Blömeke L, Post J, Kulawik A, Jürgens D, Rossberg WM, Hümpel M, Bannach O, Otto M, Araujo JA, Willuweit A, Willbold D (2023) Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease. Heliyon;9: e18443.

2. Pils M, Dybala A, Rehn F, Blömeke L, Bujnicki T, Kraemer-Schulien V, Hoyer W, Riesner D, Willbold D, Bannach O (2023). Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's Disease. Diagnostics (Basel);13:

3. Schaffrath A, Schleyken S, Seger A, Jergas H, Özdüzenciler P, Pils M, Blömeke L, Cousin A, Willbold J, Bujnicki T, Bannach O, Fink GR, Willbold D, Sommerauer

M, Barbe MT, Tamgüney G (2023) Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool. NPJ Parkinsons Dis;9: 14.

4. Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, Bujnicki T, Willbold D (2022) Abeta oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med;3: 100630.

5. Blömeke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamgüney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach

O, Chen-Plotkin A, Willbold D (2022) Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting. npj Parkinson's Disease;8: 68.

6. Kravchenko K, Kulawik A, Hülsemann M, Kühbach K, Zafiu C, Herrmann Y, Linnartz C, Peters L, Bujnicki T, Willbold J, Bannach O, Willbold D (2017) Analysis of anticoagulants for blood-based quantitation of amyloid beta oligomers in the sFIDA assay. Biological chemistry;398: 465-75.

7. Herrmann Y, Bujnicki T, Zafiu C, Kulawik A, Kühbach K, Peters L, Fabig J, Willbold J, Bannach O, Willbold D (2017) sFIDA automation yields sub-femtomolar limit of detection for Abeta aggregates in body fluids. Clinical biochemistry;50: 244-7.

8. Herrmann Y, Kulawik A, Kühbach K, Hülsemann M, Peters L, Bujnicki T, Kravchenko K, Linnartz C, Willbold J, Zafiu C, Bannach O, Willbold D (2017) Nanoparticle standards for immuno-based quantitation of alpha-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies. Clinica chimica acta; international journal of clinical chemistry;466: 152-9.